# Severity of the New UK SARS-Cov2 Variant in COVID-19 Infection

> **NCT04863547** · — · UNKNOWN · sponsor: **ANRS, Emerging Infectious Diseases** · enrollment: 2200 (estimated)

## Conditions studied

- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

## Interventions

- **OTHER:** Data collection

## Key facts

- **NCT ID:** NCT04863547
- **Lead sponsor:** ANRS, Emerging Infectious Diseases
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-03-11
- **Primary completion:** 2021-04-30
- **Final completion:** 2021-05-31
- **Target enrollment:** 2200 (ESTIMATED)
- **Last updated:** 2021-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04863547

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04863547, "Severity of the New UK SARS-Cov2 Variant in COVID-19 Infection". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04863547. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*